Explore GLOW Blend (GHK-Cu/TB-500/BPC-157) dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
GLOW Blend is a three-peptide stack that combines GHK-Cu, TB-500, and BPC-157 — the same skin-and-tissue trio without the KPV anti-inflammatory component of the larger KLOW kit. This data shows the combined dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when working with this aesthetic and connective-tissue blend.
GLOW Blend is a three-peptide stack — GHK-Cu, TB-500, and BPC-157 (the G-L-O-W naming derives from the constituent abbreviations) — assembled into a single pre-mixed lyophilized vial. It sits as the structural complement to the four-peptide KLOW kit elsewhere on this site: GLOW removes the KPV anti-inflammatory component and keeps the three peptides most associated with collagen synthesis, dermal repair, and connective-tissue regeneration, which is why researchers in the cosmetic and aesthetic literatures have gravitated toward it.
GLOW is a three-peptide research blend (GHK-Cu, BPC-157, and TB-500) most often sourced for skin, hair, and connective-tissue repair protocols. It ships as a lyophilized powder you reconstitute with bacteriostatic water before use.
GHK-Cu delivers bioavailable copper for lysyl oxidase activity and stimulates dermal fibroblasts, BPC-157 acts on the VEGF–NO pathway to drive angiogenesis in injured tissue, and TB-500 sequesters G-actin and promotes endothelial-cell migration. The three molecules engage complementary repair pathways with limited mechanistic overlap.
No published trials evaluate the fixed-ratio blend. Component-level evidence covers GHK-Cu in photoaged-skin studies (Leyden et al.), BPC-157 in tendon repair models from the Sikiric lab, and TB-500 in dermal wound healing and post-MI cardiac repair from the Goldstein/RegeneRx program.
GLOW Blend has a reported half-life of ~2 days (TB-500-driven), and the dose intervals researchers model most often fall around once daily. GLOW is a multi-peptide blend — each component has its own half-life. The longest-lived component (TB-500) drives buildup over the first 1–2 weeks; the shorter-lived components clear between doses. It is catalogued under Recovery Peptides on WPA.
2,524 GLOW Blend reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (457 calculations). The most common bacteriostatic water volume is 3mL. The most popular vial size is 70mg (1,931 sessions). The most common dosing frequency is daily (7x/week) (271 logged protocols), followed by 5x/week (100).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.